Axonics Modulation Company Insiders
| AXNX Stock | USD 70.28 0.01 0.01% |
Axonics Modulation's insiders are aggressively selling. The analysis of insiders' sentiment of trading Axonics Modulation Technologies stock suggests that vertually all insiders are panicking at this time. Axonics Modulation employs about 797 people. The company is managed by 11 executives with a total tenure of roughly 39 years, averaging almost 3.0 years of service per executive, having 72.45 employees per reported executive.
| Raymond Cohen CEO CEO, Director |
Axonics Modulation's Insider Buying Vs Selling
0
Selling | Buying |
Latest Trades
| 2024-10-02 | Kari Leigh Keese | Disposed 2961 @ 69.41 | View | ||
| 2024-01-31 | Raymond W Cohen | Disposed 35161 @ 67.74 | View | ||
| 2024-01-08 | Karen Noblett | Disposed 15999 @ 69 | View | ||
| 2023-12-28 | Karen Noblett | Disposed 7051 @ 63.28 | View | ||
| 2023-12-26 | Karen Noblett | Disposed 949 @ 63 | View |
Monitoring Axonics Modulation's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Axonics |
Axonics Modulation's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Axonics Modulation's future performance. Based on our forecasts, it is anticipated that Axonics will maintain a workforce of slightly above 800 employees by November 2024.Axonics Modulation Management Team Effectiveness
Return On Tangible Assets is likely to drop to -0.01 in 2024. Return On Capital Employed is likely to drop to -0.0073 in 2024. At this time, Axonics Modulation's Net Tangible Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 239.9 M in 2024, whereas Total Assets are likely to drop slightly above 371.4 M in 2024. Axonics Modulation's management efficiency ratios could be used to measure how well Axonics Modulation manages its routine affairs as well as how well it operates its assets and liabilities.Common Stock Shares Outstanding is likely to drop to about 34.2 M in 2024. Net Loss is likely to drop to about (56.4 M) in 2024
Axonics Modulation Workforce Comparison
Axonics Modulation Technologies is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 136,440. Axonics Modulation maintains roughly 797 in number of employees contributing less than 1% to equities under Health Care industry.
Axonics Modulation Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Axonics Modulation insiders, such as employees or executives, is commonly permitted as long as it does not rely on Axonics Modulation's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Axonics Modulation insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2024-09-01 | 1.0 | 2 | 2 | 103,896 | 103,896 |
| 2024-03-01 | 0.5 | 6 | 12 | 178,567 | 209,118 |
| 2023-09-01 | 0.2 | 1 | 5 | 11,250 | 35,694 |
| 2023-06-01 | 1.1429 | 8 | 7 | 33,209 | 45,209 |
| 2023-03-01 | 0.7143 | 35 | 49 | 481,198 | 387,672 |
| 2022-09-01 | 0.4444 | 8 | 18 | 45,083 | 195,376 |
| 2022-03-01 | 0.6667 | 30 | 45 | 528,737 | 473,950 |
| 2021-12-01 | 2.0 | 6 | 3 | 14,986 | 10,000 |
| 2021-09-01 | 0.5385 | 7 | 13 | 46,834 | 118,334 |
| 2021-06-01 | 0.4286 | 18 | 42 | 142,065 | 551,360 |
| 2021-03-01 | 0.875 | 28 | 32 | 340,522 | 190,129 |
| 2020-12-01 | 0.25 | 4 | 16 | 22,863 | 74,526 |
| 2020-09-01 | 0.3478 | 16 | 46 | 107,355 | 1,412,372 |
| 2020-06-01 | 0.4074 | 11 | 27 | 170,000 | 380,020 |
| 2020-03-01 | 0.375 | 15 | 40 | 179,142 | 1,000,572 |
| 2019-12-01 | 0.9091 | 10 | 11 | 240,080 | 795,000 |
| 2019-09-01 | 3.75 | 15 | 4 | 82,904 | 19,404 |
| 2019-06-01 | 1.6429 | 23 | 14 | 81,512 | 36,169 |
| 2019-03-01 | 22.0 | 22 | 1 | 689,610 | 0.00 |
| 2018-12-01 | 0.8676 | 59 | 68 | 30,344,484 | 22,903,177 |
Axonics Modulation Notable Stakeholders
An Axonics Modulation stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Axonics Modulation often face trade-offs trying to please all of them. Axonics Modulation's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Axonics Modulation's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Raymond Cohen | CEO, Director | Profile | |
| JD Esq | General VP | Profile | |
| Alfred Ford | Chief Commercial Officer | Profile | |
| Danny Dearen | Chief Operating and Financial Officer | Profile | |
| MD MAS | Chief Officer | Profile | |
| Rinda Sama | Chief Officer | Profile | |
| Aaron Pettit | General Officer | Profile | |
| Kari Keese | Chief Officer | Profile | |
| John Woock | Chief Marketing Officer | Profile | |
| Neil Bhalodkar | Vice Relations | Profile | |
| Guangqiang Jiang | Chief Officer | Profile |
About Axonics Modulation Management Performance
The success or failure of an entity such as Axonics Modulation often depends on how effective the management is. Axonics Modulation management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Axonics management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Axonics management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | (0.01) | (0.01) | |
| Return On Assets | (0.01) | (0.01) | |
| Return On Equity | (0.01) | (0.01) |
Please note, the imprecision that can be found in Axonics Modulation's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Axonics Modulation Technologies. Check Axonics Modulation's Beneish M Score to see the likelihood of Axonics Modulation's management manipulating its earnings.
Axonics Modulation Workforce Analysis
Traditionally, organizations such as Axonics Modulation use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Axonics Modulation within its industry.Axonics Modulation Manpower Efficiency
Return on Axonics Modulation Manpower
| Revenue Per Employee | 459.7K | |
| Revenue Per Executive | 33.3M | |
| Net Loss Per Employee | 7.6K | |
| Net Loss Per Executive | 553.5K | |
| Working Capital Per Employee | 559.1K | |
| Working Capital Per Executive | 40.5M |
Additional Tools for Axonics Stock Analysis
When running Axonics Modulation's price analysis, check to measure Axonics Modulation's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axonics Modulation is operating at the current time. Most of Axonics Modulation's value examination focuses on studying past and present price action to predict the probability of Axonics Modulation's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Axonics Modulation's price. Additionally, you may evaluate how the addition of Axonics Modulation to your portfolios can decrease your overall portfolio volatility.